Higher adherence supports both reimbursement rates from payers and the resupply of masks and accessories. ResMed also plays a key role in producing clinical data that demonstrates treatment can ...

Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder.

Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line ...

SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Wednesday reported fiscal third-quarter profit of $365 million. On a per-share basis, the San Diego-based company said it had profit of ...

Last five quarters the last, 10 quarters where we said the actual market growth rate is mid-single digits on devices, high single digits on masks. And that's if ResMed just accepts market growth ...

Sleep device maker ResMed says it has received an exemption ... The company manufactures sleep devices and masks in Australia and Singapore, which he said were protected under the Nairobi Protocol.

On the US market, it is worth more than Lululemon and eBay. Resmed makes sleep apnoea masks in Singapore and Australia, but the bulk of their trade is in North and South America. A global ...

For the three months ended 31 March, ResMed reported an 8% increase in revenue to US$1.3 billion. This was driven by increased demand for its sleep devices and masks portfolio, as well as solid ...

The CEO of ResMed, a $49b company which manufactures sleep devices to treat sleep apnea and other chronic respiratory conditions, on Thursday revealed the Trump Administration will not apply ...

Shoppers Say: "If you’re looking for a face mask to give you glass skin or plumper, brighter looking skin, this one has done it for me. The jelly consistency is great and is very cold on the ...

If your skincare routine isn’t delivering the results you’re after, it might be time to add an LED face mask to the mix. Take our word for it: Multiple Forbes Vetted staffers reported less ...